Normal view MARC view ISBD view

[Bioequivalence evaluation of orally disintegrating tablet of pentoxyverine citrate]. [electronic resource]

By:

Lin, Ming-qin

Contributor(s):

Producer: 20130624Description: 1621-3 p. digitalISSN:

1673-4254

Subject(s):

In: Nan fang yi ke da xue xue bao = Journal of Southern Medical University vol. 30

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: English Abstract; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.

There are no comments on this title.

to post a comment.

Back to results

7501 Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients.
by Naito, Takafumi
7502 Flow cytometry-based pharmacodynamic monitoring after organ transplantation.
by Dieterlen, Maja-Theresa
7503 [ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs].
by Ichikawa, Naomi
7504 Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation.
by Hooper, David K
7505 The importance of challenging your diagnosis even in straightforward cases.
by Maus, Erik Alberto
7506 Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers.
by van der Windt, Anna E
7507 Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent.
by Singla, Arvind K
7508 [Frequency of T-cell mediated rejection in new-onset diabetes after kidney transplantation].
by Borda, Bernadett
7509 Successful use of infliximab and tacrolimus in a patient with Crohn's disease.
by Cortes, Xavier
7510 Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
by Donati, Michele
7511 TOPICAL CORTICOSTEROIDS BUT NOT CALCINEURIN INHIBITORS INDUCED ATROPHY AFTER FOUR WEEKS.
by Jiráková, A
7512 [Tacrolimus-induced gynecomastia in a patient with polymyositis].
by Muñoz Gómez, María Mar
7513 Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
by Hlavaty, Kelan A
7514 Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
by Fujibayashi, Takayoshi
7515 The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population.
by Matin, Marzieh
7516 [Chronic spontaneous urticaria].
by Garriga-Companys, Silvia
7517 Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation.
by Sato, Kazushige
7518 [EPIDERMAI GROWTH FACTOR SECRETED BY ASTROCYTES STIMULATED WITH TACROLIMUS PROMOTING NEURITE OUTGROWTH].
by Cai, Jun
7519 Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravis.
by Chen, D
7520 Interactive effects of attachment and FKBP5 genotype on school-aged children's emotion regulation and depressive symptoms.
by Borelli, Jessica L